Reviva Pharmaceuticals (RVPH) Institutional Ownership $0.44 -0.03 (-6.90%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.44 +0.00 (+0.78%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Reviva Pharmaceuticals (NASDAQ:RVPH)CurrentInstitutional OwnershipPercentage63.18%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$1.05MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$1.06M Get RVPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RVPH Institutional Buying and Selling by Quarter Reviva Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025NewEdge Advisors LLC60,900$58K0.0%N/A0.130% 5/5/2025Private Advisor Group LLC200,000$191K0.0%N/A0.428% 5/2/2025BluePointe Capital Management LLC47,185$45K0.0%+354.7%0.101% 2/17/2025Tang Capital Management LLC170,000$308K0.0%N/A0.508% 2/17/2025Millennium Management LLC1,804,488$3.27M0.0%-1.5%5.396% 2/17/2025Focus Partners Wealth60,000$109K0.0%-62.7%0.179% 2/17/2025Cornerstone Select Advisors LLC17,500$32K0.0%N/A0.052% 2/17/2025Ameriprise Financial Inc.46,467$84K0.0%N/A0.139% 2/14/2025Schonfeld Strategic Advisors LLC1,058,100$1.92M0.0%-30.2%3.164% 2/14/2025Tower Research Capital LLC TRC26,775$48K0.0%+848.8%0.080% Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/13/2025XTX Topco Ltd25,020$45K0.0%N/A0.075% 2/13/2025Raymond James Financial Inc.14,000$25K0.0%N/A0.042% 2/12/2025Geode Capital Management LLC311,701$564K0.0%+11.9%0.932% 2/6/2025Raymond James Financial Inc.14,000$25K0.0%N/A0.042% 1/23/2025EMC Capital Management44,535$81K0.0%+142.0%0.133% 1/22/2025 Drive Wealth Management LLC20,000$36K0.0%N/A0.060% 11/16/2024Geode Capital Management LLC278,496$401K0.0%+17.9%0.833% 5/10/2024Vanguard Group Inc.1,001,836$3.79M0.0%+2.8%3.588% 2/13/2024Armistice Capital LLC1,764,000$9.09M0.1%+194.0%6.318% 1/30/2024 Vontobel Holding Ltd.14,000$72K0.0%N/A0.062% 11/15/2023Armistice Capital LLC600,000$2.93M0.0%-27.2%2.649% 11/9/2023EMC Capital Management123,915$613K0.4%+1,294.3%0.547% 8/7/2023Wolverine Asset Management LLC14,501$85K0.0%+137.6%0.071% 7/27/2023Virtu Financial LLC18,448$108K0.0%N/A0.090% 2/15/2023Tang Capital Management LLC24,125$103K0.0%N/A0.118% 2/13/2023EMC Capital Management123,915$527K0.5%+125.0%0.606% 2/1/2023Wolverine Asset Management LLC6,814$29K0.0%+934.0%0.033% 11/7/2022Virtu Financial LLC46,119$73K0.0%N/A0.226% 10/25/2022Raymond James & Associates33,000$52K0.0%+65.0%0.161% 2/10/2022EMC Capital Management55,078$159K0.1%-27.4%0.364% 2/3/2022Northwestern Mutual Wealth Management Co.9,299$27K0.0%N/A0.067% 11/9/2021BlackRock Inc.33,470$136K0.0%+82.7%0.241% 8/17/2021Armistice Capital LLC714,700$3.47M0.1%N/A7.742% 8/13/2021Renaissance Technologies LLC11,250$55K0.0%N/A0.122% 8/13/2021Northern Trust Corp10,584$51K0.0%N/A0.115% 8/13/2021Geode Capital Management LLC67,724$329K0.0%N/A0.734% 8/13/2021Vanguard Group Inc.529,464$2.57M0.0%N/A5.735% 7/28/2021 DAVENPORT & Co LLC10,000$49K0.0%-33.3%0.108% 5/21/2021Citadel Advisors LLC36,652$210K0.0%N/A0.397% 5/18/2021Millennium Management LLC35,310$203K0.0%N/A0.382% Digital Dollar Alert: Protect Your Wealth Before It’s Too Late (Ad)134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts warn a programmable dollar could erase your privacy and control your spending. A free guide reveals how to protect your savings before the system goes live.Download your FREE Digital Dollar Defense Kit now5/18/2021Citadel Advisors LLC36,652$210K0.0%N/A0.397% (Data available from 1/1/2016 forward) RVPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RVPH shares? During the previous two years, 19 institutional investors and hedge funds held shares of Reviva Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($9.09M), Vanguard Group Inc. ($3.79M), Millennium Management LLC ($3.27M), Schonfeld Strategic Advisors LLC ($1.92M), Geode Capital Management LLC ($564K), Tang Capital Management LLC ($308K), and Private Advisor Group LLC ($191K).Learn more on Reviva Pharmaceuticals' institutional investors. What percentage of Reviva Pharmaceuticals' stock is owned by institutional investors? 63.18% of Reviva Pharmaceuticals' stock is owned by institutional investors. Learn more on RVPH's institutional investor holdings. Which institutional investors have been buying Reviva Pharmaceuticals' stock? Of the 16 institutional investors that purchased Reviva Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.16M), Private Advisor Group LLC ($200K), Tang Capital Management LLC ($170K), EMC Capital Management ($141.16K), Geode Capital Management LLC ($75.58K), NewEdge Advisors LLC ($60.90K), and Ameriprise Financial Inc. ($46.47K). How much institutional buying is happening at Reviva Pharmaceuticals? Institutional investors have bought a total of 730,362 shares in the last 24 months. This purchase volume represents approximately $1.05M in transactions. Which of Reviva Pharmaceuticals' major shareholders have been selling company stock? The following institutional investors have sold Reviva Pharmaceuticals stock in the last 24 months: Schonfeld Strategic Advisors LLC ($457.80K), Focus Partners Wealth ($101K), and Millennium Management LLC ($28.33K). How much institutional selling is happening at Reviva Pharmaceuticals? Institutional investors have sold a total of 587,126 shares in the last 24 months. This volume of shares sold represents approximately $1.06M in transactions. Related Companies VTGN Major Shareholders ORMP Major Shareholders ARTV Major Shareholders XBIT Major Shareholders ENTX Major Shareholders MIST Major Shareholders CABA Major Shareholders QNCX Major Shareholders EPIX Major Shareholders ANRO Major Shareholders This page (NASDAQ:RVPH) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.